Breast Cancer
Article
Everolimus overcomes hormonal resistance in ER-positive breast cancer
News
Noncarriers in BRCA Families Dodge Breast Cancer Risk
Major Finding: The relative risk of developing breast cancer, 0.39, was not significantly higher among noncarriers of BRCA1 or BRCA2 mutations in...
Video
The Antiangiogenic Quagmire
News
Mammography's Role in Saving Lives Deemed Exaggerated
Major Finding: The likelihood that a breast cancer survivor’s life was saved by screening mammography is never more than 25% and typically is less...
Reviews
Meeting Highlights From the 2011 Breast Cancer Symposium
News
Multimodal DCIS Therapy, Tamoxifen Cuts Breast Cancer Deaths
Major Finding: The addition of tamoxifen to surgery and radiation reduced breast cancer death rates from 3.1% without the drug to 1.5% with it....
News
California Insurer Drops Bevacizumab Breast Cancer Coverage
News
Prone Position During Breast Irradiation Lessens Lung Cancer Risk
Major Finding: A prone position for whole breast irradiation was associated with an estimated 1.99% lifetime risk for radiation-associated...
News
Everolimus Posts Big Win in ER-Positive Breast Cancer
Major Finding: Everolimus increased median progression-free survival from 2.8 months with exemestane alone to 6.9 months (P less than .0001,...
News
Trastuzumab-Based T-DM1 Delays Breast Cancer Progression
Findings: Treatment with trastuzumab emtansine (T-DM1) resulted in a median progression-free survival of 14 months compared with 9 months for...
News
Chemo Timing Does Not Affect Breast Cancer Recurrence
Major Finding: The 10-year rate was 90% with neoadjuvant chemotherapy and 94% with the chemotherapy after surgery, but the difference lost...